
IndraLab
Statements
reach
"In contrast, it was reported that an inhibitor of KCNQ1 (chromanol 293B) significantly increased insulin secretion in the presence of sulfonylurea; this finding suggested that the activity of KCNQ1 in subjects with the C allele of rs2237897, a risk allele for type 2 diabetes, might be higher than that in subjects with the T allele, a risk allele for diabetic nephropathy in the present study."
reach
"In a physiological study in INS-1 cell cultures, the blockade of the KvLQT1 channel with KCNQ1 protein inhibitor 293B stimulated insulin secretion in the presence of sulphonylurea drug tolbutamide [XREF_BIBR], suggesting that KvLQT1 channels might play a role in fine tuning of insulin secretion during sulphonylurea treatment."
reach
"Inhibition of KCNQ1 channel activity by the selective inhibitor chromanol 293B significantly increases insulin secretion in INS-1 cells XREF_BIBR, whereas KCNQ1 overexpression in MIN6 cells results in markedly impaired insulin secretion by glucose, pyruvate, or tolbutamide XREF_BIBR."